三维生物打印胆囊癌模型的构建与评价OA
3D-bioprinted gallbladder cancer model:construction and evaluation
背景与目的:胆囊癌是一种具有高度侵袭性的消化系统恶性肿瘤,患者5年生存率不足10%.现有二维(two-dimensional,2D)细胞培养模型难以真实反映肿瘤的三维(three-dimensional,3D)组织学特征及药物反应,限制了药物筛选和机制研究.3D生物打印技术能够通过可控方式构建复杂结构的肿瘤模型,模拟体内微环境.本研究旨在利用甲基丙烯酰化明胶(gelatin methacryloyl,GelMA)构建3D生物打印胆囊癌模型,并比较其与2D模型在分子特征及药物敏感性方面的差异.方法:本研究采用NOZ人胆囊癌细胞系与GelMA水凝胶生物墨水构建3D胆囊癌模型,通过挤出式生物打印技术实现肿瘤微环境的仿真化.3D模型的细胞形态和增殖活性通过显微镜、活/死细胞染色和细胞计数试剂盒-8(cell counting kit-8,CCK-8)进行评估.RNA提取后,采用Illumina NovaSeqTM 6000平台进行RNA测序,结合DESeq2进行差异表达分析,并通过实时荧光定量聚合酶链反应(real-time fluorescence quantitative polymerase chain reaction,RTFQ-PCR)验证部分差异表达基因.药物敏感性检测通过吉西他滨(gemcitabine,GEM)、顺铂(cisplatin,DDP)、白蛋白结合型紫杉醇(nab-paclitaxel)及5-氟尿嘧啶(5-fluorouracil,5-FU)的剂量反应实验,计算半数抑制浓度(half-maximal inhibitory concentration,IC50),评估模型对不同药物的敏感性.统计学分析使用GraphPad Prism 9.0和R 4.4.0软件,P<0.05为差异有统计学意义.结果:3D模型结构稳定,细胞在水凝胶中保持较高活力并形成球状聚集,增殖能力显著高于2D模型.转录组测序共鉴定出617个差异表达基因,其中235个上调、382个下调,主要富集于细胞周期、炎症反应及细胞因子信号转导通路.RTFQ-PCR验证结果与RNA测序结果一致.药物敏感性检测结果显示,3D模型对多种化疗药物的IC50均高于2D模型,提示其更接近临床肿瘤耐药特征.结论:本研究构建了3D生物打印胆囊癌模型.与2D培养相比,3D模型对GEM、DDP、nab-paclitaxel和5-FU的敏感性更低、IC50更高,更符合临床实体瘤的耐受特征.因此,3D模型在模拟临床药物耐受和低敏感性方面优于2D,可用于耐药机制研究及候选药物/联合方案筛选验证.
Background and purpose:Gallbladder cancer is a highly aggressive gastrointestinal malignancy with a 5-year survival rate of less than 10%.Conventional two-dimensional(2D)cell cultures poorly mimic the tumor microenvironment,limiting translational drug screening.Three-dimensional(3D)bioprinting enables the construction of biomimetic tumor models with controllable structure and function.This study aimed to establish a 3D bioprinted gallbladder cancer model and compare its biological and pharmacological features with 2D cultures.Methods:The NOZ human gallbladder cancer cell line and GelMA hydrogel bioink were used to construct a 3D gallbladder cancer model via extrusion-based 3D bioprinting,aiming to simulate the tumor microenvironment.The morphology,viability,and proliferation of cells in the 3D constructs were assessed using microscopy,live/dead cell staining,and the cell counting kit-8(CCK-8)assay.Following RNA extraction,RNA sequencing was performed on the Illumina NovaSeqTM 6000 platform.Differential gene expression analysis was conducted using DESeq2,and the results for selected genes were validated by real-time fluorescence quantitative polymerase chain reaction(RTFQ-PCR).Drug sensitivity was evaluated by determining the half-maximal inhibitory concentration(IC50)through dose-response experiments with gemcitabine(GEM),cisplatin(DDP),nab-paclitaxel and 5-fluorouracil(5-FU).Statistical analyses were performed using GraphPad Prism 9.0 and R software(version 4.4.0),and P<0.05 was considered statistically significant.Results:The 3D model showed stable lattice structures with high cell viability and spheroid formation,accompanied by significantly enhanced proliferation compared with 2D cultures(P<0.001).Transcriptome analysis revealed 617 differentially expressed genes(235 upregulated,382 downregulated),enriched in cell cycle regulation,cytokine signaling,and extracellular matrix remodeling.RTFQ-PCR confirmed consistency with RNA-seq results.Drug response assays demonstrated higher IC50 in 3D models versus 2D for all agents tested,indicating reduced chemosensitivity and stronger resemblance to clinical resistance.Conclusion:This study established a 3D bioprinted gallbladder cancer model.Compared with 2D culture,the 3D model showed lower sensitivity and higher IC50 to GEM,DDP,nab-paclitaxel,and 5-FU,consistent with drug-tolerant phenotypes of clinical solid tumors.Therefore,the 3D model is superior to the 2D model in recapitulating clinically relevant drug resistance and tolerance and can be utilized for investigating drug resistance mechanisms and for screening/validating candidate drugs or combination regimens.
王铭洋;赵成;王紫迎;宋晓玲;顾钧;龚伟;杨自逸
上海交通大学医学院附属新华医院普外科,上海 200092||上海胆道疾病研究重点实验室,上海 200092上海交通大学医学院附属新华医院普外科,上海 200092||上海胆道疾病研究重点实验室,上海 200092上海交通大学医学院附属新华医院普外科,上海 200092||上海胆道疾病研究重点实验室,上海 200092上海交通大学医学院附属新华医院普外科,上海 200092||上海胆道疾病研究重点实验室,上海 200092上海交通大学医学院附属新华医院普外科,上海 200092||上海胆道疾病研究重点实验室,上海 200092上海交通大学医学院附属新华医院普外科,上海 200092||上海胆道疾病研究重点实验室,上海 200092上海交通大学医学院附属新华医院普外科,上海 200092||上海胆道疾病研究重点实验室,上海 200092
医药卫生
胆囊癌三维生物打印GelMA水凝胶转录组学药物敏感性体外模型
Gallbladder cancerThree-dimensional bioprintingGelMA hydrogelTranscriptomicsDrug sensitivityIn vitro model
《中国癌症杂志》 2026 (3)
258-267,10
上海市抗癌协会"雏鹰"计划(SACA-CY23C11)上海交通大学"交大之星"计划医工交叉研究基金青年项目(YG2024QNA19). Shanghai Anti-Cancer Association EYAS PROJECT(SACA-CY23C11)Shanghai Jiao Tong University"Jiaoda Star"Program Medical-Engineering Interdisciplinary Research Fund,Young Investigator Project(YG2024QNA19).
评论